Skip to main content
SpringerLink
Log in

Coronary revascularization in end-stage renal disease

  • Inverventional Cardiology
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Advanced coronary artery disease and acute cardiac events are the most common causes of death in patients with end-stage renal disease. Because of their heightened risk, end-stage renal disease patients are frequently referred for coronary revascularization. However, these patients are almost always excluded from trials examining various innovations in medical and revascularization interventions for cardiovascular conditions. Extrapolation of trial conclusions regarding dialysis patients can be misleading because the risk-benefit ratios of various interventions in this patient population can be markedly different. Thus, clinical decisions regarding the need for (and type of) coronary revascularization are based on retrospective outcome analyses from various databases. This article reviews the data available in the literature on the morbidity, mortality, and outcomes of dialysis patients undergoing surgical or percutaneous revascularization, particularly with the addition of drug-eluting stents to the available therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Of major importanceUS Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006. A comprehensive compilation of all data available on prevalence, morbidity, mortality, and economic aspects related to ESRD in the United States as late as 2004.

  2. Lindner A, Charra B, Sherrard DJ, Scribner BH:Accelerated atherosclerosis in prolonged maintenance hemodialysis.N Engl J Med 1974,290:697–701.

    PubMed  CAS  Google Scholar 

  3. Go AS, Chertow GM, Fan D, et al.:Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.N Engl J Med 2004,351:1296–1305.

    Article  PubMed  CAS  Google Scholar 

  4. Ohtake T, Kobayashi S, Moriya H, et al.:High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination.J Am Soc Nephrol 2005,16:1141–1148.

    Article  PubMed  Google Scholar 

  5. Herzog CA, Ma JZ, Collins AJ, et al.:Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.N Engl J Med 1998,339:799–805.

    Article  PubMed  CAS  Google Scholar 

  6. Shlipak MG, Fried LF, Crump C, et al.:Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.Circulation 2003,107:87–92.

    Article  PubMed  CAS  Google Scholar 

  7. Muntner P, Hamm LL, Kusek JW, et al.:The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.Ann Intern Med 2004,140:9–17.

    PubMed  Google Scholar 

  8. Galle J:Oxidative stress in chronic renal failure.Nephrol Dial Transplant 2001,16:2135–2137.

    Article  PubMed  CAS  Google Scholar 

  9. Luke RG:Chronic renal failure—a vasculopathic state.N Engl J Med 1998,339:841–843.

    Article  PubMed  CAS  Google Scholar 

  10. London GM, Marchais SJ, Guerin AP, et al.:Arterial structure and function in end-stage renal disease.Nephrol Dial Transplant 2002,17:1713–1724.

    Article  PubMed  Google Scholar 

  11. Suliman ME, Stenvinkel P, Qureshi AR, et al.:Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.Am J Kidney Dis 2004,44:455–465.

    Article  PubMed  CAS  Google Scholar 

  12. Schwarz U, Buzello M, Ritz E, et al.:Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.Nephrol Dial Transplant 2000,15:218–223.

    Article  PubMed  CAS  Google Scholar 

  13. Gruberg L, Rai P, Mintz GS, et al.:Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis.Am J Cardiol 2005,96:892–896.

    Article  PubMed  Google Scholar 

  14. Raggi P, Boulay A, Chasan-Taber S, et al.:Cardiac calcification in adult hemodialysis patients.A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002,39:695–701.

    Article  PubMed  Google Scholar 

  15. Charytan D, Kuntz RE:The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.Kidney Int 2006,70:2021–2030.

    PubMed  CAS  Google Scholar 

  16. Of major importance Coca SG, Krumholz HM, Garg AX, Parikh CR:Underrep-resentation of renal disease in randomized controlled trials of cardiovascular disease.JAMA 2006,296:1377–1384. An in-depth examination of the systematic pattern of exclusion of patients with renal disease from almost all high-impact trials addressing innovation in medical, surgical, and interventional therapies for cardiovascular disease.

    Article  PubMed  CAS  Google Scholar 

  17. Manske CL, Wang Y, Rector T, et al.:Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure.Lancet 1992,340:998–1002.

    Article  PubMed  CAS  Google Scholar 

  18. Szczech LA, Best PJ, Crowley E, et al.:Outcomes of patients with chronic renal insufficiency in the bypass angio-plasty revascularization investigation.Circulation 2002,105:2253–2258.

    Article  PubMed  CAS  Google Scholar 

  19. Szczech LA, Reddan DN, Owen WF, et al.:Differential survival after coronary revascularization procedures among patients with renal insufficiency.Kidney Int 2001,60:292–299.

    Article  PubMed  CAS  Google Scholar 

  20. Herzog CA, Ma JZ, Collins AJ, et al.:Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes.Circulation 2002,106:2207–2211.

    Article  PubMed  Google Scholar 

  21. Liu JY, Birkmeyer NJ, Sanders JH, et al.:Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group.Circulation 2000,102:2973–2977.

    PubMed  CAS  Google Scholar 

  22. Charytan DM, Kuntz RE:Risks of coronary artery bypass surgery in dialysis-dependent patients—analysis of the 2001 National Inpatient Sample.Nephrol Dial Transplant 2007,22:1665–1671.

    Article  PubMed  Google Scholar 

  23. Cooper WA, O’Brien SM, Thourani VH, et al.:Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database.Circulation 2006,113:1063–1070.

    Article  PubMed  Google Scholar 

  24. Koyanagi T, Nishida H, Kitamura M, et al.:Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients.Ann Thorac Surg 1996,61:1793–1796.

    Article  PubMed  CAS  Google Scholar 

  25. Rinehart AL, Herzog CA, Collins AJ, et al.:A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients.Am J Kidney Dis 1995,25:281–290.

    Article  PubMed  CAS  Google Scholar 

  26. Ahmed WH, Shubrooks SJ, Gibson CM, et al.:Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients.Am Heart J 1994,128:252–255.

    Article  PubMed  CAS  Google Scholar 

  27. Marso SP, Gimple LW, Philbrick JT, DiMarco JP,Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis.Am J Cardiol 1998,82:378–380.

    Article  PubMed  CAS  Google Scholar 

  28. Kahn JK, Rutherford BD, McConahay DR, et al.:Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients.Am Heart J 1990,119:484–489.

    Article  PubMed  CAS  Google Scholar 

  29. Azar RR, Prpic R, Ho KK, et al.:Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting.Am J Cardiol 2000,86:485–489.

    Article  PubMed  CAS  Google Scholar 

  30. Le Feuvre C, Dambrin G, Helft G, et al.:Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting.Heart 2001,85:556–560.

    Article  PubMed  Google Scholar 

  31. Lemos PA, Arampatzis CA, Hoye A, et al.:Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents.Am J Cardiol 2005,95:167–172.

    Article  PubMed  CAS  Google Scholar 

  32. Kuchulakanti PK, Torguson R, Chu WW, et al.:Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.Am J Cardiol 2006,97:792–797.

    Article  PubMed  CAS  Google Scholar 

  33. Lemos PA, Serruys PW, van Domburg RT, et al.:Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.Circulation 2004,109:190–195.

    Article  PubMed  CAS  Google Scholar 

  34. Hassani SE, Chu WW, Wolfram RM, et al.:Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.J Invasive Cardiol 2006,18:273–277.

    PubMed  Google Scholar 

  35. Of importance Das P, Moliterno DJ, Charnigo R, et al.:Impact of drugeluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.J Invasive Cardiol 2006,18:405–408. The first published report retrospectively comparing bare metal stents with DES in ESRD patients.

    PubMed  Google Scholar 

  36. Of importance Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.J Invasive Cardiol 2006,18:577–83. Although small and retrospective, this study is one of the few comparisons between bare metal and drug-eluting stents in ESRD published to date.

    PubMed  Google Scholar 

  37. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al.:Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.J Am Coll Cardiol 2006,48:2584–2591.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, 900 South Limestone Street, 326 C.T. Wethington Building, 40536, Lexington, KY, USA

    Khaled M. Ziada MD

Authors
  1. Khaled M. Ziada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khaled M. Ziada MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziada, K.M. Coronary revascularization in end-stage renal disease. Curr Cardiol Rep 9, 389–395 (2007). https://doi.org/10.1007/BF02938366

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938366

Keywords

Search

Navigation